Wegovy tablets offer a convenient alternative to the injectable version of the drug.
Our readers read next
Aid cuts and war complicate Ebola response in Congo
The number of cases is likely to be far higher than currently reported, WHO warns.
May 18
6 mins read
A decision on whether Britain’s National Health Service will cover the drug is expected in November.
Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill
The move is estimated to cost the state around €100 million (US$116 million) annually at full roll-out.
Britain's regulator has approved Novo Nordisk's weight-loss pill, marking the UK's entry as the first European market for this…
France will cover the costs of weight-loss drugs from 15 June, according to the country's health minister.
Top health official says insurers could cover weight-loss drugs "under certain conditions"
